HopeStage
Back to all studies
UnknownNCT06505668

Effect of Atenolol Versus Ivabradine on HRV in TRS Patients on Clozapine With Tachycardia: A Randomised Control Trial.

Medication studyAges 18–60IndiaSchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 60 years.

Listed locations
BhubaneswarSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: August 1, 2023
Recruitment status
Unknown
Enrollment listed in the registry
40
Sponsor
All India Institute of Medical Sciences, Bhubaneswar
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Locations
India
Age range
From 18 Years to 60 Years
Official registry ID
NCT06505668
Official title
Show the full official title

Effect Of Atenolol Versus Ivabradine On Heart Rate Variability In Treatment Resistant Schizophrenia Patients On Clozapine With Tachycardia: A Randomized Control Trial.

Recruitment & locations

Status unknown

Bhubaneswar

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is All India Institute of Medical Sciences, Bhubaneswar, a research institute.

Does this study involve medication?

Yes. The study involves medication, including Atenolol 25 mg and Ivabradine 10mg.

Who can participate?

Listed age limits: 18 years to 60 years.

Want to explore more studies?

Explore studies